Cefpirome indications

Revision as of 15:56, 2 January 2014 by Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Cefpirome}} {{CMG}} ==Indications== '''''Infections caused by CEFROM-sensitive organisms:'''''<ref>{{Cite web | last = | first = | title = http://pk.sanofi-av...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cefpirome
CEFROM® Package Insert
Composition
Properties
Indications
Microbiology
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Indications

Infections caused by CEFROM-sensitive organisms:[1]

  • Infections in neutropenic and immunocompromised patients
  • Skin and soft tissue infections
  • Severe infections in intensive care patients

Infections caused by the following pathogens have been successfully treated in clinical trials:

Gram-Positive Organisms
  • Streptococci of groups B and F
  • Streptococcus of viridans groups
Gram-negative organisms

In Vitro Sensitivity

Gram positive organisms
Gram-negative organisms

Most strains of the following species showing in vitro sensitivity

Gram-positive organisms
Gram-Negative Organisms

Most strains of the following species are resistant in vitro

Gram-Positive Organisms
  • Listeria monocytogenes
Gram-Negative Organisms

References

  1. "http://pk.sanofi-aventis.com/products/Cefrom.pdf" (PDF). External link in |title= (help)